RLMD earnings
Relmada Therapeutics (RLMD) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
RLMD earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.11 | -0.20 | 44.87% | – |
| Q1 2026 | May 12, 2026 | -0.22 | -0.18 | -22.22% | – |
| Q4 2025 | Mar 19, 2026 | -0.27 | -0.14 | -92.86% | – |
| Q3 2025 | Nov 13, 2025 | -0.30 | -0.04 | -650.00% | – |
| Q2 2025 | Aug 7, 2025 | -0.30 | -0.25 | -20.00% | – |
| Q1 2025 | May 12, 2025 | -0.58 | -0.31 | -87.10% | – |
| Q4 2024 | Mar 27, 2025 | -0.62 | -0.70 | 11.43% | – |
| Q3 2024 | Nov 7, 2024 | -0.72 | -0.65 | -10.77% | – |
| Q2 2024 | Aug 7, 2024 | -0.59 | -0.83 | 28.92% | – |
| Q1 2024 | May 8, 2024 | -0.72 | -0.90 | 20.00% | – |
| Q4 2023 | Mar 19, 2024 | -0.84 | -0.88 | 4.55% | – |
| Q3 2023 | Nov 8, 2023 | -0.73 | -0.95 | 23.16% | – |
| Aug 8, 2023 | -0.84 | -0.92 | 8.70% | – | |
| May 11, 2023 | -0.87 | -0.88 | 1.14% | – | |
| Mar 23, 2023 | -1.26 | -1.33 | 5.26% | – | |
| Nov 10, 2022 | -1.31 | -1.40 | 6.43% | – | |
| Aug 11, 2022 | -1.33 | -1.30 | -2.31% | – | |
| May 5, 2022 | -1.40 | -1.21 | -15.70% | – | |
| Mar 23, 2022 | -1.80 | -1.60 | -12.50% | – | |
| Nov 11, 2021 | -2.44 | -1.62 | -50.62% | – |
- RLMD reports next on Nov 12, 2026, with EPS of -0.15 expected.
- RLMD beat EPS estimates in 13 of its last 31 reports.
Updated 2026-11-05 12:49 UTC